News | May 12, 2026
Dr. Reddy’s to participate in HSBC, Bank of America investor conferences
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
Subscribe To Our Newsletter & Stay Updated
